Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (18)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2019

  1. Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

    Lung Cancer, Vol. 134, pp. 72-78

  2. Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping

    Annals of Oncology, Vol. 30, Núm. 2, pp. 290-296

  3. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas

    Journal of the American Heart Association, Vol. 8, Núm. 18, pp. e012875

  4. Phase I/II trial to evaluate the efficacy and safety of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with pancreatic cancer and an ECOG performance status of 2

    Journal of Clinical Oncology

  5. Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3

    Cell Reports, Vol. 27, Núm. 13, pp. 3956-3971.e6

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Proteomic analysis of connexin 43 reveals novel interactors related to osteoarthritis

    Molecular and Cellular Proteomics, Vol. 14, Núm. 7, pp. 1831-1845

  2. Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis

    Oncologist, Vol. 20, Núm. 2, pp. 111-112

2014

  1. Lipoprotein(a) levels in familial hypercholesterolemia: An important predictor of cardiovascular disease independent of the type of LDL receptor mutation

    Journal of the American College of Cardiology, Vol. 63, Núm. 19, pp. 1982-1989

  2. Sky1 regulates the expression of sulfur metabolism genes in response to cisplatin

    Microbiology (United Kingdom), Vol. 160, Núm. PART 7, pp. 1357-1368

2013

  1. Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases

    PLoS ONE, Vol. 8, Núm. 7

2012

  1. Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer

    Breast Cancer Research and Treatment, Vol. 132, Núm. 1, pp. 307-315

2010

  1. The transcriptional response of normal and rheumatoid arthritis synovial fibroblasts to hypoxia

    Arthritis Care and Research, Vol. 62, Núm. 12, pp. 3584-3594

2008

  1. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain

    Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869

2005

  1. Critically short telomeres are associated with sperm DNA fragmentation

    Fertility and Sterility, Vol. 84, Núm. 4, pp. 843-845

2002

  1. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: Differential diagnosis from Hodgkin's lymphoma

    Histopathology, Vol. 41, Núm. 3, pp. 216-229